Evidence map›Paper›PMID 38007648›Full record

Trial reportJournal of Alzheimer's disease : JAD2023

Effect of Nordic Sensi® Chair on Behavioral and Psychological Symptoms of Dementia in Nursing Homes Residents: A Randomized Controlled Trial.

José María García-Alberca, María Dolores de la Rosa, Paloma Solo de Zaldívar, María Ledesma, Estela Oltra, Esther Gris, Olga Ocejo, Javier Torrecilla, Carmen Zafra, Ana Sánchez-Fernández and 7 more

Erratum issuedOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of Alzheimer's disease : JAD, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

José María García-AlbercaAlzheimer Research Center and Memory Clinic, Instituto Andaluz de Neurociencia (IANEC), Málaga, Spain.
María Dolores de la RosaAlzheimer Research Center and Memory Clinic, Instituto Andaluz de Neurociencia (IANEC), Málaga, Spain.
Paloma Solo de ZaldívarAlzheimer Research Center and Memory Clinic, Instituto Andaluz de Neurociencia (IANEC), Málaga, Spain.
María LedesmaAlzheimer Research Center and Memory Clinic, Instituto Andaluz de Neurociencia (IANEC), Málaga, Spain.
Estela OltraAlzheimer Research Center and Memory Clinic, Instituto Andaluz de Neurociencia (IANEC), Málaga, Spain.
Esther GrisAlzheimer Research Center and Memory Clinic, Instituto Andaluz de Neurociencia (IANEC), Málaga, Spain.
Olga OcejoCentro Residencial Almudena, Rincón de laVictoria, Spain.
Javier TorrecillaCentro Residencial Almudena, Rincón de laVictoria, Spain.
Carmen ZafraCentro Residencial Almudena, Rincón de laVictoria, Spain.
Ana Sánchez-FernándezResidencia DomusVi Fuentesol, Alhaurín de la Torre, Spain.
Tomás MancillaResidencia DomusVi Fuentesol, Alhaurín de la Torre, Spain.
Mercedes López-RomeroResidencia DomusVi Fuentesol, Alhaurín de la Torre, Spain.
Raquel JerezAlzheimer Research Center and Memory Clinic, Instituto Andaluz de Neurociencia (IANEC), Málaga, Spain.
Nuria SantanaAlzheimer Research Center and Memory Clinic, Instituto Andaluz de Neurociencia (IANEC), Málaga, Spain.
José Pablo LaraBrain Health Unit, School of Medicine, University of Málaga, Málaga, Spain.
Miguel Ángel BarbanchoBrain Health Unit, School of Medicine, University of Málaga, Málaga, Spain.
Encarnación Blanco-ReinaPharmacology and Therapeutics Department, School of Medicine, University of Málaga, Málaga, Spain.
Instituto de Neurociencias · ESUniversidad de Málaga · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBehavioral and psychological symptoms of dementia (BPSD) are present in most people with dementia (PwD), including Alzheimer's disease. There is consensus that non-pharmacological therapies represent the first line of treatment to address BPSD.

objectiveWe explore the efficacy of the use of a rocking chair (Nordic Sensi® Chair, NSC) in the treatment of BPSD in nursing home residents with moderate and severe dementia.

methodsWe carried out a 16-week randomized, single-blind, controlled, clinical trial with PwD admitted to nursing homes. Participants were assigned to a treatment group (n = 40) that received three times a week one session per day of 20 minutes in the NSC and a control group (n = 37). The Neuropsychiatric Inventory-Nursing Home (NPI-NH) was used as primary efficacy outcome. Occupational distress for the staff was evaluated using the NPI-NH Occupational Disruptiveness subscale (NPI-NH-OD). Statistical analyses were conducted by means of a Mixed Effects Model Analysis.

resultsTreatment with the NSC was associated with a beneficial effect in most of BPSD, as reflected by differences between the treatment and control group on the NPI-NH total score (mean change score -18.87±5.56 versus -1.74±0.67, p = 0.004), agitation (mean change score -2.32±2.02 versus -0.78±1.44, p = 0.003) and irritability (mean change score -3.35±2.93 versus -1.42±1.31, p = 0.004). The NPI-NH-OD total score also improved the most in the treatment group (mean change score -9.67±7.67 versus -7.66±6.08, p = 0.003).

conclusionsThe reduction in overall BPSD along with decreased caregiver occupational disruptiveness represent encouraging findings, adding to the potential of nonpharmacological interventions for nursing home residents living with dementia.

Indexed as

Alzheimer DiseaseDementiaBehavioral SymptomsHumansNursing HomesSingle-Blind MethodAlzheimer’s diseasebehavioral and psychological symptoms of dementiadementianon-pharmacological interventionnursing home

Identifiers

PMID38007648
PMCPMC10741310
OpenAlexW4388866466

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.